BloombergUS
Lilly Pushes Buying Spree Beyond $32B With Calytrix Deal
Eli Lilly & Co. agreed to buy closely held Calytrix Bio Inc. in a deal that could be worth up to $1.5 billion, the latest in the drugmaker’s…